These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30369906)

  • 1. Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features.
    Limphaibool N; Iwanowski P; Holstad MJV; Perkowska K
    Front Neurol; 2018; 9():857. PubMed ID: 30369906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications.
    Limphaibool N; Iwanowski P; Holstad MJV; Kobylarek D; Kozubski W
    Front Neurol; 2019; 10():652. PubMed ID: 31275235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.
    Helley MP; Pinnell J; Sportelli C; Tieu K
    Front Genet; 2017; 8():177. PubMed ID: 29204154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye Movements in Parkinson's Disease and Inherited Parkinsonian Syndromes.
    Pretegiani E; Optican LM
    Front Neurol; 2017; 8():592. PubMed ID: 29170650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease--a multifactorial neurodegenerative disorder.
    Riess O; Krüger R
    J Neural Transm Suppl; 1999; 56():113-25. PubMed ID: 10370906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.
    Palin EJ; Paetau A; Suomalainen A
    Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.
    Giannoccaro MP; La Morgia C; Rizzo G; Carelli V
    Mov Disord; 2017 Mar; 32(3):346-363. PubMed ID: 28251677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism.
    Lin G; Wang L; Marcogliese PC; Bellen HJ
    Trends Endocrinol Metab; 2019 Feb; 30(2):106-117. PubMed ID: 30528460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited metabolic disorders involving the eye: a clinico-biochemical perspective.
    Rajappa M; Goyal A; Kaur J
    Eye (Lond); 2010 Apr; 24(4):507-18. PubMed ID: 19798114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: experimental models and reality.
    Jiang P; Dickson DW
    Acta Neuropathol; 2018 Jan; 135(1):13-32. PubMed ID: 29151169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbances of Sleep and Alertness in Parkinson's Disease.
    Videnovic A
    Curr Neurol Neurosci Rep; 2018 Apr; 18(6):29. PubMed ID: 29675716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of Parkinson's disease.
    Mullin S; Schapira A
    Br Med Bull; 2015 Jun; 114(1):39-52. PubMed ID: 25995343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatment.
    Chin LS; Li L
    Transl Neurodegener; 2016; 5():1. PubMed ID: 26740872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular changes in the postmortem parkinsonian brain.
    Toulorge D; Schapira AH; Hajj R
    J Neurochem; 2016 Oct; 139 Suppl 1():27-58. PubMed ID: 27381749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.